Clinical Trials Logo

Bipolar Depression clinical trials

View clinical trials related to Bipolar Depression.

Filter by:

NCT ID: NCT00926393 Completed - Bipolar Depression Clinical Trials

Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression

Start date: June 2009
Phase: Phase 4
Study type: Interventional

The purpose of the study is to compare the sedation profile one hour after dose administration between Seroquel IR and Seroquel XR.

NCT ID: NCT00914680 Completed - Bipolar Depression Clinical Trials

Berlin Magnetic Seizure Therapy Depression Trial 01

Start date: June 2009
Phase: Phase 3
Study type: Interventional

This treatment pilot study will investigate clinical efficacy and adverse effects of magnetic seizure therapy (MST) in patients currently experiencing a unipolar or bipolar depressive episode. The investigators will perform add-on tests to assess clinical and cognitive response to treatment. It is hypothesized that MST will have an antidepressant efficacy with a beneficial neurocognitive adverse effect profile.

NCT ID: NCT00908154 Completed - Bipolar Disorder Clinical Trials

Safety, Tolerability and Pharmacokinetics of Repeat Doses of GSK1014802.

Start date: May 31, 2008
Phase: Phase 1
Study type: Interventional

GSK1014802 is a use-dependent sodium channel blocker and an effective anticonvulsant in animal models. This study is being conducted to obtain information regarding the safety, tolerability and pharmacokinetics of repeated doses of GSK1014802 administered for up to 28 days in healthy male or female subjects. In addition, the effect of food on the pharmacokinetics of GSK1014802 will be investigated.

NCT ID: NCT00893841 Completed - Bipolar Depression Clinical Trials

Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride

Start date: February 2009
Phase: Phase 2
Study type: Interventional

This study is designed to assess the use of pramipexole dihydrochloride and quetiapine (Seroquel) XR as combination therapy for bipolar depression. The proposed benefit of the combination therapy investigated in this study is improved treatment of bipolar depression.

NCT ID: NCT00868959 Completed - Bipolar Depression Clinical Trials

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Start date: April 2009
Phase: Phase 3
Study type: Interventional

This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe for the treatment of patients with bipolar I depression

NCT ID: NCT00868699 Completed - Bipolar Depression Clinical Trials

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)

Start date: April 2009
Phase: Phase 3
Study type: Interventional

This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe for the treatment of patients with bipolar I depression

NCT ID: NCT00868452 Completed - Bipolar Depression Clinical Trials

Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)

Start date: April 2009
Phase: Phase 3
Study type: Interventional

This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe when added to treatment with lithium or Divalproex for the treatment of patients with bipolar I depression.

NCT ID: NCT00857584 Completed - Bipolar Disorder Clinical Trials

Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on Therapy

Start date: May 2009
Phase: Phase 3
Study type: Interventional

Prospective, open-label, controlled (active comparator), randomized study of 8 weeks follow-up for the evaluation of the efficacy of extended release quetiapine (quetiapine XR) versus Sertraline in addition to previous mood stabilizer treatment (lithium or valproate at stable and clinically therapeutic blood levels) in the treatment of the adult bipolar depression. This multicentric study will be featured in two sites in Spain.

NCT ID: NCT00852202 Completed - Bipolar Depression Clinical Trials

Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression

Start date: June 30, 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety, and tolerability of cariprazine in the treatment of outpatients with bipolar depression.

NCT ID: NCT00844857 Completed - Bipolar Depression Clinical Trials

A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression

Start date: April 2009
Phase: Phase 4
Study type: Interventional

The main goal of this study is to help answer the following research question(s) and not to treat the child's illness. - Can this study drug make children with bipolar depression feel better? - Does this study drug work better than a placebo (sugar pill)? - Does this study drug cause side effects in children who take it? - Is this drug safe to use in children? (The study drug is a mixture of olanzapine and fluoxetine)